Repurposing antivirals as potential treatments for SARS-CoV-2: From SARS to COVID-19
David Gómez-Ríos, Víctor A. López-Agudelo, Howard Ramírez-Malule
DOI: 10.7324/JAPS.2020.10501Pages: 001-009
Medicinal and therapeutic potential of withanolides from Withania somnifera against COVID-19
Manish Dhawan, Manisha Parmar, Khan Sharun, Ruchi Tiwari, Muhammad Bilal, Kuldeep Dhama
DOI: 10.7324/JAPS.2021.110402Pages: 006-013
Formulation rationale for the development of SARS-COV-2 immunochromatography rapid test kits in India
Prince Manta, Raveen Chauhan, Himanshu Gandhi, Shikha Mahant, Deepak N. Kapoor
DOI: 10.7324/JAPS.2021.1101017Pages: 128-133
Unravelling the potentialities of tocilizumab for the development of a potential immunotherapeutic regimen against COVID-19—A narrative review
Manish Dhawan, Kuldeep Dhama, Manisha Parmar, Alisha Sharma, Steffy Angural
DOI: 10.7324/JAPS.2021.1101104Pages: 026–033
Variations from SARS-CoV-2 to Omicron: A new threat knocking at World’s door
Acharya Balkrishna, Akansha Rohela, Ashwani Kumar, Vedpriya Arya, Nazam Khan
DOI: 10.7324/JAPS.2022.120404Pages: 037-043
Characterization in silico of bioactive compound in tea plant as a potentials inhibitor of SARS-CoV-2 Mpro
Mohamad Endy Yulianto, Ari Yuniastuti, Dadan Rohdiana, Vita Paramita, Hermawan Dwi Ariyanto, Rizka Amalia, Sutrisno Sutrisno, Indah Hartati, Shabri Shabri, Retno Dwi Nyamiati, Siti Rahmawati
DOI: 10.7324/JAPS.2022.120909Pages: 076-085
The role of influenza vaccination in the COVID-19 infection: Impact on incidence and severity in Iraq
Ahmed Mohammed Taqi Al Mosawi, Haitham Mahmood Kadhim, Hussam Majeed Hameed
DOI: 10.7324/JAPS.2022.120813Pages: 130-136
Seroprevalence of SARS-CoV-2 antibodies among Jordanian citizens: A cross-sectional study of the demographic and clinical factors that ameliorate serum IgG concentration
Walid Abu Rayyan
DOI: 10.7324/JAPS.2022.121116Pages: 151-156
.webp)
Identification of potential bioactive compounds from Azadirachta indica (Neem) as inhibitors of SARS-CoV-2 main protease: Molecular docking and molecular dynamics simulation studies
Donny Ramadhan, Firdayani Firdayani, Nihayatul Karimah, Elpri Eka Permadi, Sjaikhurrizal El Muttaqien, Agus Supriyono
DOI: 10.7324/JAPS.2023.139799Pages: 040-049
Molecular modeling of lupeol for antiviral activity and cellular effects
P. B. Lalthanpuii, C. Lalrinmawia, B. Lalruatfela, Lal Ramliana, K. Lalchhandama
DOI: 10.7324/JAPS.2023.145048Pages: 131-143
Computer-aided drug design of novel nirmatrelvir analogs inhibiting main protease of Coronavirus SARS-CoV-2
Kateryna O. Lohachova, Anastasiia S. Sviatenko, Alexander Kyrychenko, Volodymyr V. Ivanov, Tierry Langer, Sergiy M. Kovalenko, Oleg N. Kalugin
DOI: 10.7324/JAPS.2024.158114Pages: 232-239
In silico design of sitagliptin bioisosteres as new inhibitors of Mpro SARS-CoV-2
Abelardo Abad-Giron, Lucero Asmad-Cruz, Angella M. Cordova-Muñoz, Cesar D. Gamarra-Sanchez, Carmen R. Silva-Correa, Víctor E. Villarreal-La Torre
DOI: 10.7324/JAPS.2024.192856Pages: 145-155
Repurposing of eluxadoline as a SARS-CoV-2 main protease inhibitor: E-Pharmacophore based virtual screening, molecular docking, MM-GBSA calculations, and molecular dynamics simulations studies
Magdi A. Mohamed, Alaa F. Alanazi, Waad A. Alanazi, Tilal Elsaman, Malik S. Mohamed, Eyman M. Eltayib
DOI: 10.7324/JAPS.2024.204792Pages: 102-110
The effect of Citrus reticulata peel extract containing hesperidin on inhibition of SARS-CoV-2 infection based on pseudovirus entry assays
Endah Puji Septisetyani, Hayfa Salsabila Harsan, Dennaya Kumara, Pekik Wiji Prasetyaningrum, Komang Alit Paramitasari, Anisa Devi Cahyani, Khairul Anam, Ria Fajarwati Kastian, Adi Santoso, Muthi Ikawati, Edy Meiyanto
DOI: 10.7324/JAPS.2025.195397Pages: 205-214
_.jpg)